U.S. Physical Therapy, Inc.
USPH
$77.42
$0.06990.09%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 150.70M | 148.21M | 137.43M | 138.55M | 129.45M |
| Total Other Revenue | 31.24M | 30.39M | 28.89M | 26.92M | 24.60M |
| Total Revenue | 181.94M | 178.60M | 166.31M | 165.47M | 154.05M |
| Cost of Revenue | 145.09M | 127.97M | 133.75M | 131.61M | 121.64M |
| Gross Profit | 36.85M | 50.63M | 32.56M | 33.86M | 32.41M |
| SG&A Expenses | 16.25M | 15.57M | 14.39M | 14.25M | 14.09M |
| Depreciation & Amortization | 5.54M | 17.85M | -- | -- | 3.89M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 166.88M | 161.40M | 148.13M | 145.86M | 139.61M |
| Operating Income | 15.06M | 17.20M | 18.18M | 19.61M | 14.44M |
| Income Before Tax | 17.33M | 18.32M | 12.34M | 14.80M | 14.76M |
| Income Tax Expenses | 3.86M | 5.83M | 2.56M | 3.08M | 3.14M |
| Earnings from Continuing Operations | 13.47M | 12.49M | 9.78M | 11.71M | 11.62M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.57M | -3.25M | -3.15M | -4.21M | -3.57M |
| Net Income | 9.90M | 9.24M | 6.63M | 7.51M | 8.05M |
| EBIT | 15.06M | 17.20M | 18.18M | 19.61M | 14.44M |
| EBITDA | 20.93M | 22.89M | 22.57M | 24.13M | 18.54M |
| EPS Basic | 0.80 | 0.52 | 0.39 | 0.47 | 0.46 |
| Normalized Basic EPS | 0.30 | 0.44 | 0.52 | 0.50 | 0.36 |
| EPS Diluted | 0.80 | 0.52 | 0.39 | 0.47 | 0.46 |
| Normalized Diluted EPS | 0.30 | 0.44 | 0.52 | 0.50 | 0.36 |
| Average Basic Shares Outstanding | 15.13M | 15.09M | 15.08M | 15.07M | 15.02M |
| Average Diluted Shares Outstanding | 15.13M | 15.09M | 15.08M | 15.07M | 15.02M |
| Dividend Per Share | 0.45 | 0.44 | 0.44 | 0.44 | 0.44 |
| Payout Ratio | -- | 71.85% | 100.09% | 176.71% | -- |